Share Name Share Symbol Market Type Share ISIN Share Description
Midatech Pharma LSE:MTPH London Ordinary Share GB00BRTL9B63 ORD 0.005P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 126.00p 125.00p 127.00p 126.00p 125.50p 126.00p 2,930.00 12:28:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.4 -11.2 -36.0 - 61.36

Midatech Pharma Share Discussion Threads

Showing 201 to 224 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
21/1/2017
20:51
Panmure reiterate target of 297p and N+1 Singer 283p. You pays yer money and takes yer chance.
deltrotter
21/1/2017
13:23
Weekly view - the triple share purchase is code for its on the turn. The multi strategy blurb prob means the one that's doing well isn't the one your expecting. Still, he's saying something is selling well. Williams looks LT bowly & poss some inst bites on the volume in anticipation of swinging to profit. Don't how long that is so maybe a longer term play - but CEO & Panmure are dropping hints - poss to inst buyers too who may fancy it here (half IPO) or adjusting their avg entry weight. The tallest volume spikes look like an inst trader trying to nail the btm. The technical damage of the 3 long black bars needs to be repaired at some point (ie go back to the green line).
luckymouse
20/1/2017
11:43
I sold this morning. This announcement was nothing new and the price will drift back if they have no other news.
martinwj
20/1/2017
11:21
n an analyst rating update on Friday shares of Midatech Pharma Plc (LON:MTPH) had their rating reiterated by analysts at Panmure Gordon. The broker said it has now set a ‘Buy’ rating on shares of Midatech Pharma Plc with a price target of 297.
deltrotter
20/1/2017
11:20
Sorry double post.
jamtomorrow2
20/1/2017
11:20
Double digit sales growth in US based Dara in 2017. Big deal eh! You'd get more than that just on the exchange rate difference. This company has had no good news since the IPO. About time one of their many R&D projects showed some promise. What about the two child patients in the brain cancer trial? Not a mention of their progress. Surely if they were making good progress then every hospital around the world would be requesting a similar trial on their patients. But not a word. Everything is SO slow.
jamtomorrow2
20/1/2017
09:43
Good news this AM. Looks like the signals from the recent volume uptick in the US were a good pointer to a positive statement. Brokers have a target price well north of this price so suspect this has some way to run.
gwatson56
20/1/2017
08:51
Yup, the plan was to have their own sales team in place for when their own products are launched. Bigger profits that way. This stock has a long long way to run IMO.
deltrotter
20/1/2017
08:38
Quite like the two part commercialisation strategy with revenues flowing now from the US with a suite of own products in development and hopefully commercialisation in 2018/2019.
hutch_pod
20/1/2017
07:30
That seems to be revenue above forecasts of £8.6m
18bt
18/1/2017
19:05
It also went up 9% on NASDAQ yesterday. Odd
martinwj
18/1/2017
18:56
Yup, chunky price rise in the US....
deltrotter
18/1/2017
18:55
Volume over on the Nasdaq has spiked today (as has the price). Gave up on buying any more on the LSE at the official buy price as I was only offered 20 shares. Believe that more were available at a higher price (see someone paid 1.29).
gwatson56
13/1/2017
15:35
I have high hopes for this stock in 2017. Having said that, I am 60% down on it, so my opinion is probably worthless! Would I buy more now? Yes.
deltrotter
13/1/2017
15:31
There appears to be little on offer as I have not been able to buy any decent size parcel this PM. The best I could get (going through more than one broker on-line) was 500 shares. So if the recent large trades were sells they have been snapped up or the MM's are holding on to them.... Thought that the MMS was 1000 .... still gives me hope for my existing holding....
gwatson56
11/1/2017
18:11
3 interesting delayed trades - 2 million pounds worth - over 3% of the market cap. Must be buys or the price would have plummeted? 16:10:38 11-Jan-2017 120.00 839,388 1,007,265.60 Ordinary Trade - delayed publication 16:10:32 11-Jan-2017 120.00 590,000 708,000.00 Ordinary Trade - delayed publication 16:10:24 11-Jan-2017 120.00 250,000 300,000.00 Ordinary Trade - delayed publication
martinwj
03/1/2017
12:41
http://uk.advfn.com/cmn/fbb/thread.php3?id=40148137 This thread now has a more useful header!
solonic
15/12/2016
16:40
And there is an insti picking up 500k....
deltrotter
15/12/2016
10:43
Yes. At least the cash has been sorted.
hutch_pod
14/12/2016
13:37
I am still confident on this one longer term, but boy has it taken a helluva hit.
deltrotter
14/12/2016
13:00
Suspect we will hear soon re the completion of expansion of Bilbao manufacturing facility for scale-up of sustained release technology.
gwatson56
23/11/2016
08:49
Ditto. Onwards.
hutch_pod
23/11/2016
07:50
I certainly did. I am hoping for a much improved performance hear in 2017 and their US sales strategy kicks in and we hear news on their trials.
deltrotter
22/11/2016
22:29
Thanks. Hope you took up the offer?
hutch_pod
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170221 14:32:44